At-Home Paracentesis for Women With Cancer-Related Malignant Ascites (Paracentesis)
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT07490626
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Malignant Ascites
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- At-home Paracentesis — PROCEDUREParacentesis is a bedside procedure to obtain ascitic fluid from the peritoneum through needle aspiration, performed for both diagnostic and therapeutic purposes. The procedure involves needle insertion into the peritoneal cavity to remove fluid for analysis or to relieve symptoms from tense ascites.
Study Details
The goal of this study is to evaluate the change in symptoms for women with cancer-related malignant ascites who complete an at-home paracentesis procedure.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: At-home ParacentesisParticipants receive an at-home-based paracentesis procedure, which may occur anytime following confirmation of eligibility.
Primary Outcome Measure
The change in the 3-item AIM (Ascites Impact Measure)-TSS (Total Symptom Score) from before at-home paracentesis to after at-home paracentesis. [ Time Frame: 3 months ]
Central Contacts
- Susan Sharry801-585-3453
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Huntsman Cancer Institute at the University of Utah | Salt Lake City | Utah | 84112 |
Find similar trials in Salt Lake City, UT
Related Studies
- Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic CancerPHASE1 · Recruiting · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania